Industry News
Cold Chain Platform to Host MMCS Workshop For Asia
| Update : 25th August, 2021 |
On 29th September 2021 Korea-based digital pharma-logistics hub, the Cold Chain Platform (CCP), is running a workshop to introduce a new GDP (Good Distribution Practice) support initiative for the pharma industry.
London, 24th Aug 2021: Following on from a highly successful introductory workshop that took place in Europe in July 2021, the British Standards Institution (BSI) and Poseidon have partnered with the Cold Chain Platform (CCP) in Korea to introduce the MMCS (Multi-Mode Compliance & Standards) GDP program to pharma manufacturers and their pharma-logistics partners across the Asia Pacific region.
A partnership between the British Standards Institution (BSI) and the Poseidon pharma-logistics network, the MMCS program is a global, ‘first-of-its-kind’ initiative with the express aim of championing the development of universal GDP standards, efficient quality management systems, mutually-recognised assessment schemes, supply chain best practice and the provision of professional GDP guidance.
Alan Kennedy, Director at Team Poseidon Ltd, explains further: “The MMCS has been conceived to provide a collaborative foundation for all modes of bulk pharma and vaccine transportation – air, sea, and land – around which can be built the universal GDP standards and GDP guidance needed for the safer, more efficient and fully compliant transportation of vital pharmaceuticals in the virus age.”
The workshop is relevant to all companies and personnel that are involved in the storage and distribution of medicines - Responsible Persons, manufacturers, distributors, LSPs, carriers, suppliers etc. All workshop participants will be given the opportunity to join the MMCS Consultation Cluster which has been established to identify and consolidate the needs, views and experience of the industry's GDP stakeholders and sub-sectors across all roles, organisational types and geographic locations.
This free CCP virtual event for Asia will be held on Wednesday 29th September at 15.00pm Seoul /Tokyo time. Interested parties can register HERE.
About BSI
BSI is the business improvement and standards company that enables organizations to turn standards of best practice into habits of excellence, ‘inspiring trust for a more resilient world’. For over a century BSI has driven best practice in organizations around the world. Working with over 77,500 clients across 195 countries, it is a truly global business with skills and experience across all sectors including automotive, aerospace, built environment, food and retail and healthcare. Through its expertise in Standards and Knowledge, Assurance Services, Regulatory Services and Consulting Services, BSI helps clients to improve their performance, grow sustainably, manage risk and ultimately become more resilient. To learn more, please visit: www.bsigroup.com
About Poseidon
The Poseidon program is an industry reform initiative conceived to improve the conveyance of pharmaceutical products by ocean and other modes of transport. This is being achieved through the application of contemporary supply chain best-practice and structured, multi-party collaboration. The strength of the Poseidon program rests in the collective energy and resource of its end-to-end supply chain structure built around managed strategic partnerships, commercial alignment and a ‘one-team’ culture. The Poseidon network is open to all shippers of pharmaceutical finished products and ingredients. To learn more, please visit: To learn more, please visit: www.poseidon.team
About Cold Chain Platform (CCP)
Cold Chain Platform (CCP) is 100% focused on cold chain and logistics in the bio-pharmaceutical, life science, and healthcare industries. CCP services help global companies reach the right partners and get a firm foothold in Asia Pacific. CCP works with global organizations to help them gain access to the APAC cold chain, logistics, and pharmaceutical market through a highly targeted audience. To learn more, please visit: www.coldchainplatform.com
About GDP*
Good distribution practice (GDP) describes the minimum standards that a wholesale distributor must meet to ensure that the quality and integrity of medicines is maintained throughout the supply chain. Compliance with GDP ensures that: • medicines in the supply chain are authorised in accordance with European Union (EU) legislation; • medicines are stored in the right conditions at all times, including during transportation; • contamination by or of other products is avoided; • an adequate turnover of stored medicines takes place; • the right products reach the right addressee within a satisfactory time period.
*European Medicines Agency
